BLUE BIRD CORP (BLBD)

US0953061068 - Common Stock

51.87  +2.08 (+4.18%)

After market: 51.87 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BLBD. BLBD was compared to 131 industry peers in the Machinery industry. BLBD has only an average score on both its financial health and profitability. BLBD has a correct valuation and a medium growth rate.



5

1. Profitability

1.1 Basic Checks

BLBD had positive earnings in the past year.
In the past year BLBD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLBD reported negative net income in multiple years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 17.57%, BLBD belongs to the top of the industry, outperforming 96.12% of the companies in the same industry.
The Return On Equity of BLBD (75.80%) is better than 98.45% of its industry peers.
BLBD has a better Return On Invested Capital (33.82%) than 99.22% of its industry peers.
Industry RankSector Rank
ROA 17.57%
ROE 75.8%
ROIC 33.82%
ROA(3y)-2.3%
ROA(5y)0.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BLBD has a Profit Margin of 6.36%. This is comparable to the rest of the industry: BLBD outperforms 58.14% of its industry peers.
In the last couple of years the Profit Margin of BLBD has declined.
The Operating Margin of BLBD (9.72%) is comparable to the rest of the industry.
BLBD's Operating Margin has improved in the last couple of years.
BLBD has a Gross Margin of 17.69%. This is in the lower half of the industry: BLBD underperforms 75.97% of its industry peers.
In the last couple of years the Gross Margin of BLBD has remained more or less at the same level.
Industry RankSector Rank
OM 9.72%
PM (TTM) 6.36%
GM 17.69%
OM growth 3Y22.15%
OM growth 5Y5.9%
PM growth 3Y14.85%
PM growth 5Y-5.7%
GM growth 3Y3.86%
GM growth 5Y0.59%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BLBD is creating value.
BLBD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BLBD has been increased compared to 5 years ago.
BLBD has a better debt/assets ratio than last year.

2.2 Solvency

BLBD has an Altman-Z score of 6.52. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BLBD (6.52) is better than 86.82% of its industry peers.
BLBD has a debt to FCF ratio of 0.82. This is a very positive value and a sign of high solvency as it would only need 0.82 years to pay back of all of its debts.
The Debt to FCF ratio of BLBD (0.82) is better than 90.70% of its industry peers.
BLBD has a Debt/Equity ratio of 0.88. This is a neutral value indicating BLBD is somewhat dependend on debt financing.
BLBD has a Debt to Equity ratio of 0.88. This is in the lower half of the industry: BLBD underperforms 79.07% of its industry peers.
Even though the debt/equity ratio score it not favorable for BLBD, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 0.82
Altman-Z 6.52
ROIC/WACC3.88
WACC8.71%

2.3 Liquidity

A Current Ratio of 1.23 indicates that BLBD should not have too much problems paying its short term obligations.
BLBD has a worse Current ratio (1.23) than 87.60% of its industry peers.
A Quick Ratio of 0.56 indicates that BLBD may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.56, BLBD is doing worse than 89.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.56

5

3. Growth

3.1 Past

BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 471.79%, which is quite impressive.
Measured over the past years, BLBD shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.41% on average per year.
BLBD shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.17%.
Measured over the past years, BLBD shows a small growth in Revenue. The Revenue has been growing by 2.02% on average per year.
EPS 1Y (TTM)471.79%
EPS 3Y9.28%
EPS 5Y-8.41%
EPS Q2Q%229.63%
Revenue 1Y (TTM)26.17%
Revenue growth 3Y8.81%
Revenue growth 5Y2.02%
Sales Q2Q%15.38%

3.2 Future

Based on estimates for the next years, BLBD will show a very negative growth in Earnings Per Share. The EPS will decrease by -16.90% on average per year.
The Revenue is expected to grow by 13.23% on average over the next years. This is quite good.
EPS Next Y171.21%
EPS Next 2Y72.29%
EPS Next 3Y-16.9%
EPS Next 5YN/A
Revenue Next Year18.79%
Revenue Next 2Y14.72%
Revenue Next 3Y8.58%
Revenue Next 5Y13.23%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.89 indicates a rather expensive valuation of BLBD.
Compared to the rest of the industry, the Price/Earnings ratio of BLBD indicates a somewhat cheap valuation: BLBD is cheaper than 70.54% of the companies listed in the same industry.
BLBD is valuated rather cheaply when we compare the Price/Earnings ratio to 24.41, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.33, the valuation of BLBD can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLBD indicates a somewhat cheap valuation: BLBD is cheaper than 65.89% of the companies listed in the same industry.
BLBD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.89
Fwd PE 16.33

4.2 Price Multiples

BLBD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BLBD is cheaper than 65.12% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BLBD is valued cheaper than 85.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.01
EV/EBITDA 11.63

4.3 Compensation for Growth

BLBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BLBD's earnings are expected to decrease with -16.90% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y72.29%
EPS Next 3Y-16.9%

0

5. Dividend

5.1 Amount

No dividends for BLBD!.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (7/26/2024, 7:19:20 PM)

After market: 51.87 0 (0%)

51.87

+2.08 (+4.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.68B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 17.89
Fwd PE 16.33
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.57%
ROE 75.8%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.72%
PM (TTM) 6.36%
GM 17.69%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.76
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.23
Quick Ratio 0.56
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)471.79%
EPS 3Y9.28%
EPS 5Y
EPS Q2Q%
EPS Next Y171.21%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.17%
Revenue growth 3Y8.81%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y